Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Immuneering (IMRX) Return on Sales (2020 - 2023)

Immuneering's Return on Sales history spans 4 years, with the latest figure at 1158.83% for Q3 2023.

  • On a quarterly basis, Return on Sales fell 115545.0% to 1158.83% in Q3 2023 year-over-year; TTM through Sep 2023 was 1158.83%, a 115788.0% decrease, with the full-year FY2022 number at 1.59%, down 143.0% from a year prior.
  • Return on Sales came in at 1158.83% for Q3 2023, down from 13.55% in the prior quarter.
  • The five-year high for Return on Sales was 0.06% in Q3 2020, with the low at 1158.83% in Q3 2023.
  • Historically, Return on Sales has averaged 105.63% across 4 years, with a median of 0.64% in 2021.
  • Biggest five-year swings in Return on Sales: decreased -5bps in 2021 and later plummeted -115545bps in 2023.
  • Year by year, Return on Sales stood at 0.09% in 2020, then crashed by -560bps to 0.58% in 2021, then tumbled by -51047bps to 296.02% in 2022, then crashed by -291bps to 1158.83% in 2023.
  • Business Quant data shows Return on Sales for IMRX at 1158.83% in Q3 2023, 13.55% in Q2 2023, and 3.89% in Q1 2023.